This paper examines implantable electronic health record (EHR) microchips—FDA-approved devices that store patient health data under the skin. The paper outlines how these microchips reduce preventable medical errors, improve clinical decision-making for high-risk patients (diabetes, organ transplant, dementia), and streamline emergency care. It also addresses significant disadvantages, particularly privacy threats from eavesdropping, unauthorized data access, and RFID tracking capabilities. The paper concludes that despite security concerns, the clinical benefits and low implementation cost ($0.50 per chip) make implantable EHRs a promising component of future healthcare, provided privacy safeguards are strengthened.
An electronic health record (EHR) is a digital record of a patient's health information generated from every medical visit. This information includes the patient's medical history, demographics, known drug allergies, progress notes, follow-up visits, medications, vital signs, immunizations, laboratory data, and radiological reports. The EHR automates and streamlines a clinician's workflow.
Due to multiple advantages of EHRs, healthcare agencies have actively promoted this technology. In 2004, the FDA approved an implantable EHR microchip for patients. Each microchip contains a specific code identified through sensors and is implanted under the skin on the back of the arm in a twenty-minute procedure requiring no sutures.
According to the Centers for Disease Control and Prevention, deaths due to preventable medical errors rank as the fifth most common cause of death. These errors can be attributed to human factors, the complexity of medicine itself, and system failures. Exhaustion and fatigue from long work hours, unfamiliar settings, time pressures, stress, and inability to recognize the severity of certain symptoms are human factors that may contribute to medical errors.
Implantable EHR devices can decrease healthcare agencies' need for large workforces by providing physicians with easily retrievable, continuous, and accurate data. This reduces errors stemming from poor communication among on-call residents and nurses. The devices also address problems with continuity of care and excessive work hours, thereby promoting patient safety.
These devices also minimize errors involved with system failures. Disconnected reporting systems within a hospital can cause major misunderstandings that may prove lethal for patients. The implantable EHR provides physicians and healthcare facilities with documentation of every step of patient care, offering valuable evidence for medicolegal proceedings.
Implantable microchip devices were mainly recommended for patients with diabetes, stroke, seizure disorder, and organ transplants. Most of these patients require daily documentation of their health status. For example, patients with uncontrolled diabetes require daily monitoring of blood glucose levels and urinary ketones in healthcare settings. Their medication dosages must be adjusted according to blood glucose levels, sometimes on a daily basis.
Patients with organ transplants also require regular laboratory results to monitor electrolytes, check for infection, and assess treatment response. These workups are extensive and often must be reviewed by multiple physicians to determine progress and control complications. The implantation of microchip EHR devices eliminates recall bias, charting time, and charting errors. They also help different physicians understand each other's clinical approach without having to investigate from scratch.
Implantable EHR devices have also been advocated for patients with dementia, Alzheimer's disease, developmental disorders, and patients with depressive disorders or schizophrenia. These patients often struggle to express their health concerns, greatly handicapping a physician's diagnosis. Furthermore, tracking these patients through implantable records becomes necessary for their safety in case of adverse events.
Emergency medicine greatly benefits from this technology, as it provides clinicians with a brief overview of the patient's health status—especially useful for patients presenting in severe distress or shock. For patients with acute conditions, such as acute myocardial infarction, these devices can provide valuable metrics, such as symptom-to-hospital time, which are crucial for deciding treatment options.
"Critical vulnerabilities in implantable EHR systems"
"Cost-benefit analysis and future implementation prospects"
You’re 64% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.